Bell DR - Search Results

1

Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme.

Marx GM, Pavlakis N, McCowatt S, Boyle FM, Levi JA, Bell DR, Cook R, Biggs M, Little N, Wheeler HR. Marx GM, et al. Among authors: bell dr. J Neurooncol. 2001 Aug;54(1):31-8. doi: 10.1023/a:1012554328801. J Neurooncol. 2001. PMID: 11763420 Clinical Trial.

2

A phase II trial of oral 4'demethoxydaunorubicin in advanced colorectal carcinoma.

Presgrave P, Woods R, Dalley D, Bell D, Levi J. Presgrave P, et al. Am J Clin Oncol. 1988 Oct;11(5):564-5. doi: 10.1097/00000421-198810000-00011. Am J Clin Oncol. 1988. PMID: 3177259

3

Phase II study of high dose epirubicin in combination with cyclophosphamide in patients with advanced breast cancer.

Levi JA, Beith JM, Snyder RD, Tattersall MH, Bell D, Wheeler H. Levi JA, et al. Aust N Z J Med. 1995 Oct;25(5):474-8. doi: 10.1111/j.1445-5994.1995.tb01490.x. Aust N Z J Med. 1995. PMID: 8588767 Clinical Trial.

4

Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma.

Boyle F, Pendlebury S, Bell D. Boyle F, et al. Int J Radiat Oncol Biol Phys. 1995 Jan 15;31(2):315-23. doi: 10.1016/0360-3016(93)E0110-R. Int J Radiat Oncol Biol Phys. 1995. PMID: 7836085

5

Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung.

Beith JM, Clarke SJ, Woods RL, Bell DR, Levi JA. Beith JM, et al. Among authors: bell dr. Eur J Cancer. 1996 Mar;32A(3):438-43. doi: 10.1016/0959-8049(95)00608-7. Eur J Cancer. 1996. PMID: 8814688 Review.

6

Fatal pulmonary toxicity resulting from treatment with gemcitabine.

Pavlakis N, Bell DR, Millward MJ, Levi JA. Pavlakis N, et al. Among authors: bell dr. Cancer. 1997 Jul 15;80(2):286-91. doi: 10.1002/(sici)1097-0142(19970715)80:2<286::aid-cncr17>3.0.co;2-q. Cancer. 1997. PMID: 9217042

7

A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.

Hitchins RN, Bell DR, Woods RL, Levi JA. Hitchins RN, et al. Among authors: bell dr. J Clin Oncol. 1987 Oct;5(10):1655-62. doi: 10.1200/JCO.1987.5.10.1655. J Clin Oncol. 1987. PMID: 3309199 Clinical Trial.

8

Cisplatin plus VP 16-213 in advanced ovarian carcinoma.

Harnett PR, Bell DR, Hillcoat BL, Woods RL, Levi JA, Rome RM, Campbell JC, Tattersall MH. Harnett PR, et al. Among authors: bell dr. Gynecol Oncol. 1988 Jun;30(2):159-62. doi: 10.1016/0090-8258(88)90019-4. Gynecol Oncol. 1988. PMID: 3371739

9

A phase II trial of oral 4'demethoxydaunorubicin (DMDR) in inoperable non small cell lung cancer.

Presgrave P, Woods R, Kefford R, Bell D, Raghavan D, Levi J. Presgrave P, et al. Invest New Drugs. 1988 Sep;6(3):219-21. doi: 10.1007/BF00175402. Invest New Drugs. 1988. PMID: 2847993

10

Objective radiological disease control with sandostatin monotherapy in metastatic neuroendocrine tumours.

Khasraw M, Townsend A, Price T, Hart J, Bell D, Pavlakis N. Khasraw M, et al. Intern Med J. 2010 Jun;40(6):453-8. doi: 10.1111/j.1445-5994.2010.02245.x. Intern Med J. 2010. PMID: 20636828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

329 results

Search Page